Indoleamine 2,3-Dioxygenase antibody | 10.1
Mouse anti Human Indoleamine 2,3-Dioxygenase
- Product Type
- Monoclonal Antibody
- Clone
- 10.1
- Isotype
- IgG3
- Specificity
- Indoleamine 2,3-Dioxygenase
Mouse anti Human Indoleamine 2,3-Dioxygenase antibody, clone 10.1 recognizes Indoleamine-pyrrole 2,3 - dioxygenase (IDO), an enzyme responsible for the catabolism of tryptophan to N-formylkynurenine and kynurenine. With the exception of tryptophan oxidase in hepatocytes, IDO is the only enzyme that degrades the amino acid tryptophan to kynurenine. Chlamydial pathogens require tryptophan for growth. IDO can lower available tryptophan in target cells leading to conversion of the pathogen to persistant forms, with significance in the progression to chronic infection with its associated pathological effects. |
- Target Species
- Human
- Species Cross-Reactivity
-
Target Species Cross Reactivity Mouse - N.B. Antibody reactivity and working conditions may vary between species.
- Product Form
- Purified IgG - liquid
- Preparation
- Antibody purified from ascites
- Buffer Solution
- Phosphate buffered saline
- Preservative Stabilisers
- 0.1% Sodium Azide (NaN3)
- Immunogen
- Peptide corresponding to amino acids 78-184 of human IDO fused to GST.
- Approx. Protein Concentrations
- IgG concentration 1.0 mg/ml
- Regulatory
- For research purposes only
- Guarantee
- 12 months from date of despatch
Avoid repeated freezing and thawing as this may denature the antibody. Storage in frost-free freezers is not recommended.
Application Name | Verified | Min Dilution | Max Dilution |
---|---|---|---|
Immunohistology - Frozen | |||
Western Blotting |
- Western Blotting
- OBT2037G recognizes a 45kDa band in IFN-gamma treated human cell lines. This antibody recognizes a slightly lower molecular weight band in Mouse IDO compared to its human counterpart.
References for Indoleamine 2,3-Dioxygenase antibody
-
Muller, A.J. et al. (2005) Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy.
Nat Med. 11 (3): 312-9. -
Sakash, J.B. et al. (2002) Cytokines induce indoleamine 2,3-dioxygenase expression in human atheroma-asociated cells: implications for persistent Chlamydophila pneumoniae infection.
Infect Immun. 70 (7): 3959-61. -
Feder-Mengus, C. et al. (2008) High expression of indoleamine 2,3-dioxygenase gene in prostate cancer.
Eur J Cancer. 44 (15): 2266-75. -
Kudo-Saito, C. et al. (2013) CCL2 is critical for immunosuppression to promote cancer metastasis.
Clin Exp Metastasis. 30 (4): 393-405. -
Zuliani, T. et al. (2013) Fetal fibroblasts and keratinocytes with immunosuppressive properties for allogeneic cell-based wound therapy.
PLoS One. 8 (7): e70408. -
Ortiz-Lazareno, P.C. et al. (2017) Heme oxygenase and indoleamine regulation by cytokines in cervical cancer cells and natural killer cells cytotoxic activity
Gac Mex Oncol. 16 (5): 270-5.
- RRID
- AB_620055
- UniProt
- P14902
- Entrez Gene
- IDO1
- GO Terms
- GO:0009055 electron carrier activity
- GO:0005829 cytosol
- GO:0004833 tryptophan 2,3-dioxygenase activity
- GO:0055114 oxidation-reduction process
- GO:0006569 tryptophan catabolic process
- GO:0007565 female pregnancy
- GO:0020037 heme binding
- GO:0033754 indoleamine 2,3-dioxygenase activity
OBT2037G
146145 159819 163423If you cannot find the batch/lot you are looking for please contact our technical support team for assistance.
Please Note: All Products are "FOR RESEARCH PURPOSES ONLY"
View all Anti-Human ProductsAlways be the first to know.
When we launch new products and resources to help you achieve more in the lab.
Yes, sign me up